Syngene International Limited (NSE:SYNGENE)
440.75
+0.45 (0.10%)
Jun 19, 2026, 3:30 PM IST
Syngene International Market Cap
Syngene International has a market cap or net worth of 175.46 billion as of June 18, 2026. Its market cap has decreased by -31.83% in one year.
Market Cap
175.46B
Enterprise Value
167.16B
Revenue
37.39B
Ranking
n/a
PE Ratio
56.00
Stock Price
440.75
Market Cap Chart
Since August 11, 2015, Syngene International's market cap has increased from 62.11B to 175.46B, an increase of 182.50%. That is a compound annual growth rate of 10.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 175.46B | -32.30% |
| Dec 31, 2025 | 259.16B | -24.09% |
| Dec 31, 2024 | 341.40B | 22.54% |
| Dec 29, 2023 | 278.60B | 19.79% |
| Dec 30, 2022 | 232.57B | -5.39% |
| Dec 31, 2021 | 245.81B | -3.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.38T |
| Divi's Laboratories | 1.80T |
| Apollo Hospitals Enterprise | 1.21T |
| Cipla | 1.09T |
| Pfizer | 207.66B |
| Eris Lifesciences | 198.23B |
| OneSource Specialty Pharma | 189.30B |
| Sagility | 186.46B |